# Piedmont Reproductive Endocrinology Group, PA – FDA Inspection, Jan 9, 2026

Source: https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/a2c79c9a-3be3-4b19-99db-18b5584e0af2
Source feed: FDA_Inspections

> FDA inspection 1298188 of Piedmont Reproductive Endocrinology Group, PA, January 09, 2026. 2 citations under 21 CFR part 1271. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1298188
- Company Name: Piedmont Reproductive Endocrinology Group, PA
- Inspection Date: 2026-01-09
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Atlanta District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1187380 - 2022-11-01
- FDA Inspection 1091218 - 2019-05-21
- FDA Inspection 1016583 - 2017-06-27

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/amy-a-johnson/9933f793-503f-45c5-8837-d46134c20e09)

Company: https://www.keypedia.com/companies/piedmont-reproductive-endocrinology-group-pa/c852a71c-7b48-4de7-80e0-4999c4e09a02

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7
